Cargando…
ERG overexpression plus SLC45A3 (prostein) and PTEN expression loss: Strong association of the triple hit phenotype with an aggressive pathway of prostate cancer progression
TMPRSS2 and SLC45A3 rearrangements may coexist in the same tumor. ERG rearrangements and PTEN loss are concomitant events in prostate cancer (PrCa), and can cooperate in progression. We have reported that mRNA expression of TMPRSS2-ERG and SLC45A3-ERG rearrangements plus PTEN loss define an aggressi...
Autores principales: | Hernández-Llodrà, Silvia, Juanpere, Nuria, de Muga, Silvia, Lorenzo, Marta, Gil, Joan, Font-Tello, Alba, Agell, Laia, Albero-González, Raquel, Segalés, Laura, Merino, José, Serrano, Laia, Fumadó, Lluís, Cecchini, Lluís, Lloreta-Trull, Josep |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Impact Journals LLC
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5650326/ https://www.ncbi.nlm.nih.gov/pubmed/29088771 http://dx.doi.org/10.18632/oncotarget.18266 |
Ejemplares similares
-
Sentinel Lymph Node Biopsy in Prostate Cancer Patients: Results From an Injection Technique Targeting the Index Lesion in the Prostate Gland
por: Fumadó, Lluís, et al.
Publicado: (2022) -
Sensitivity of HOXB13 as a Diagnostic Immunohistochemical Marker of Prostatic Origin in Prostate Cancer Metastases: Comparison to PSA, Prostein, Androgen Receptor, ERG, NKX3.1, PSAP, and PSMA
por: Kristiansen, Ilka, et al.
Publicado: (2017) -
Identification of an HLA-A(*)0201-restricted T-cell epitope derived from the prostate cancer-associated protein prostein
por: Kiessling, A, et al.
Publicado: (2004) -
Diagnostic utility of p501s (prostein) in comparison to prostate specific antigen (PSA) for the detection of metastatic prostatic adenocarcinoma
por: Yin, Ming, et al.
Publicado: (2007) -
The impact of mutational clonality in predicting the response to immune checkpoint inhibitors in advanced urothelial cancer
por: Boll, Lilian Marie, et al.
Publicado: (2023)